Beauty

RoC tests retinol on identical twins, adding Oura Ring data to clinical skin measures

The brand has finished a twin-based pilot pairing genetic near-matches with wearable sleep and stress tracking, and is recruiting 30 pairs for a 12-week phase due to report by mid-2027.

Dalia MansourNovember 12, 20265 min read15 views
Two mirrored translucent skin-tissue panels rest on a laboratory bench, one lit by a soft glow from a generic smart ring beside it, sketching a twin-based skincare study that pairs biometric tracking with clinical skin measurement.

RoC Skincare is testing its Patented Clinical Retinol on pairs of identical twin sisters while logging their sleep and stress with Oura Rings, an approach the brand says could sharpen how it separates genetic ageing from the wear and tear of daily life.

Art Pellegrino, the company's chief scientific officer, says the pilot phase was designed to answer a methodological question first: whether identical twins could provide a more precise way to study what drives visible skin ageing. In his account, the answer was yes.

Why twins serve as a control

Identical twins share DNA and much of their early environment, so differences that emerge between them are harder to write off as genetic, Pellegrino explains. That, he says, makes it easier to observe what a retinol regimen is actually doing on skin. He describes such pairs as close to a natural control: if their skin ages differently, lifestyle and environment become the likelier explanation.

Pilot results and their limits

According to Pellegrino, twins assigned to the placebo group ended the pilot with similar or worse signs of ageing, while those in the treatment group showed improvement of 20% or more within just four weeks. The figure is presented as a signal from a small pilot, not as proof of efficacy across a broader population.

He is explicit about what the pilot did not do: it made no attempt to measure how much skin ageing stems from genes versus lifestyle. That question is left to the expanded phase, which is intended to examine how daily habits such as sleep and stress shift the picture when genetics are held constant.

Wearables as a second data stream

Throughout the study, participants wear an Oura Ring, a wearable that records health and wellness metrics through the day, capturing variation in sleep, stress, heart rate, heart rate variability and temperature trends.

Pellegrino argues that wearables are giving the wider industry a way to factor in how people actually live when recommending skin care. Because sun exposure, diet and other external influences cannot be guaranteed identical, RoC is recruiting twins with comparable levels of environmental damage wherever possible and tracking lifestyle factors closely for the duration.

With genetics effectively neutralised by the twin pairing and lifestyle tracked directly by the ring, the brand expects to relate stressors to changes in each participant's skin. If one sister sleeps poorly or reports more stress, researchers can check whether her skin responds differently to the regimen than her twin's — for instance whether weeks of poor sleep line up with lower hydration readings, or whether the less stressed twin sees fine lines soften faster.

RoC is also looking in the other direction, exploring whether participants who see visible improvements in their skin subsequently report feeling less stressed.

Skin changes are assessed with the brand's standard clinical toolkit:

  • expert grading of the signs of skin ageing;
  • digital photography;
  • corneometer readings; and
  • participants' own self-assessments.

The next phase

For the expanded study, RoC is recruiting at least 30 pairs of adult female identical twins aged 40 and older living in the US, who will use the regimen for 12 weeks. Pellegrino says the deliberately narrow group is meant to yield cleaner data to build on, and frames the work as one stage in a longer research programme on what the brand calls skin span — how long skin keeps looking its best.

Results from the twin study are expected by mid-2027. Pellegrino says the findings will shape how RoC develops products aimed at skin longevity and how it designs its clinical studies going forward.